Cathepsin K as a novel amyloid fibril protein in humans

Reinhold P. LinkeReference Center of Amyloid Diseases, München, GermanyCorrespondence[email protected]

Louise C. SerpellSchool of Life Sciences, University of Sussex, Brighton, UK

Friedrich LottspeichMax Planck Institute of Biochemistry, Martinsried, Germany

Mitsuyasu ToyodaDepartment of Surgical Pathology, Tokyo Medical College Hospital Nishishinjuku, Sinjuku-ku, Tokyo, Japan

"Cathepsin K as a novel amyloid fibril protein in humans." Amyloid, 24(1), pp. 68–69

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cathepsin K as a novel amyloid fibril protein in humans

Information for

Open access

Opportunities

Help and information

Cathepsin K as a novel amyloid fibril protein in humans

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature